SEARCH

SEARCH BY CITATION

References

  • Amoroso A, Spencer DE & Redfield RR (2004) Improving on success: what treating the urban poor in America can teach us about improving antiretroviral programmes in Africa. AIDS 18(Suppl. 3), S39S43.
  • Bisson GP & Stringer JSA (2009) Lost but not forgotten-the economics of improving patient retention in AIDS treatment programs. PLoS medicine 6, e1000174.
  • Bisson GP, Gaolathe T, Gross R et al. (2008) Overestimates of survival after HAART: implications for global scale-up efforts. PLoS ONE 3, e1725.
  • Braitstein P, Brinkhof MW, Dabis F et al. (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367, 817824.
  • Brinkhof MW, Dabis F, Myer L et al. (2008) Early loss to program in HIV infected patients starting potent antiretroviral therapy in lower-income countries. Bull World Health Organization 86, 55967 doi:10.2471/BLT.07.044248 pmid:18670668.
  • Bwirire LD, Fitzgerald M, Zachariah R et al. (2008) Reasons for loss to follow-up among mothers registered in a prevention-of-mother-to-child transmission program in rural Malawi. Transactions of the Royal Society of Tropical Medicine and Hygiene 102, 11951200.
  • CDC (2006) Facility-based HIV care/ART reporting form instructions. Center for Disease Control and Prevention, Atlanta, GA, USA. http://www.cdc.gov.
  • Etard JF, Ndjaye I, Thierry-Mieg M et al. (2006) Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS 20, 11811189.
  • Farmer P, Leandre F, Mukherjee JS et al. (2001) Community-based approaches to the treatment of advanced HIV disease, introducing DOT-HAART. Bulletin of the World Health Organization 79, 11451151.
  • Ferradini L & Leakhena S (2007) Outcomes of Adults Receiving Second-line ART in Médecins Sans Frontières-supported Projects in Resources-limited Countries. Conference on Retroviruses and Opportunistic Infections (CROI), February 25–28 2007, Los Angeles.
  • Ferradini L, Jeannin A, Pinoges L et al. (2006) Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet 367, 13351342.
  • Gross R, Bilker WB, Friedman HM et al. (2001) Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS 15, 21092111.
  • Hofer CB, Schechter M & Harrison LH (2004) Factors Associated with Antiretroviral Adherence in Public Clinics in Rio de Janeiro. International Conference on AIDS July 11–16, 2004; 15: abstract no. WeOrB1319.
  • Koenig PS, Riviere C, Leger P et al. (2008) The cost of antiretroviral therapy in Haiti. Cost Effectiveness and Resource Allocation 6, 3.
  • Lanoy E, Mary-Krause M, Tattevin P et al. (2006) Predictors identified for losses to follow-up among HIV-seropositive patients. Journal of Clinical Epidemiology 59, 829835.
  • Lawn SD, Myer L, Orrell C, Bekker LG & Wood R (2005) Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 19, 21412148.
  • Losina E, Touré H, Uhler LM et al. (2009) Cost-Effectiveness of Preventing Loss to Follow-up in HIV Treatment Programs: A Côte d’Ivoire Appraisal. PLoS Med 6(10): e10000173. doi:10.1371/journal.pmed.1000173.
  • Lucas GM, Chaisson RE & Moore RD (1999) Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Annals of Internal Medicine 131, 8187.
  • Martin W, Brinkhof G, Dabis F et al. (2008) Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bulletin of the World Health Organization 86, 497576.
  • Mukherjee JS, Ivers L, Leandre F, Farmer P & Behforouz H (2006) Antiretroviral therapy in resource-poor settings decreasing barriers to access and promoting adherence. Journal of Acquired Immune Deficiency Syndrome 43, S123S126.
  • Rosen S, Fox MP & Gill CJ (2007) Patient retention in antiretroviral therapy programs in Sub-Saharan Africa: a systematic review. PLoS Med 4(10): e298. doi:10.1371/journal.pmed.0040298.
  • Schneider H et al. (2007) Can the Public Sector Rise to the Challenge of ART? Evidence from Second Generation Sites in Gauteng Province. Third South African AIDS Conference, Durban, abstract 474.
  • Severe P, Leger P, Charles M et al. (2005) Antiretroviral therapy in a thousand patients with AIDS in Haiti. New England Journal of Medicine 353, 749751.
  • UNAIDS/WHO/UNICEF (2008a) Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector. WHO, Geneva.
  • UNAIDS/WHO/UNICEF (2008b) Nearly Three Million HIV-Positive People Now Receiving Life-Saving Drugs. WHO Media release, Geneva.
  • Variava E (2007) Reasons for Loss to Follow-Up and Defaulter Tracing After 2 years of ART Programme. Third South African AIDS Conference, Durban, abstract 590 2007.
  • Walton D, Farmer P, Lambert W et al. (2004) Integrated HIV prevention and care strengthens primary health care: lessons from rural Haiti. Journal of Public Health Policy 25, 137158.
  • WHO (2006) Treating 3 Million by 2005: Making it Happen. WHO, Geneva.
  • Wools-Kaloustian K & Kimaiyo S (2006) Extending HIV care in resource-limited settings. Current HIV/AIDS Report 4, 182186.